Open AccessOxygen toxicity seizures during United States Navy Treatment Table 6: An acceptable risk in monoplace chambers?
Author(s) -
Samantha Bonnington,
Neil Banham,
Kevin T. Foley,
Ian C Gawthrope
Publication year - 2021
Publication title -
diving and hyperbaric medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.389
H-Index - 20
eISSN - 2209-1491
pISSN - 1833-3516
DOI - 10.28920/dhm51.2.167-172
Subject(s) - hyperbaric oxygen , decompression illness , oxygen toxicity , medicine , anesthesia , decompression sickness , toxicity , decompression , emergency medicine , surgery , lung
Hyperbaric oxygen treatment (HBOT) may be complicated by oxygen toxicity seizures, which typically occur with hyperbaric partial pressures of oxygen exceeding 203 kPa (2 atmospheres absolute). All other hyperbaric units in Australia exclusively use a multiplace chamber when treating with United States Navy Treatment Table 6 (USN TT6) due to this perceived risk. The purpose of this study was to determine the safety of a monoplace chamber when treating decompression illness (DCI) with USN TT6.